France and Sweden join forces for life science innovation

Report this content

Pressrelease, April 29, 2026

STOCKHOLM – At a roundtable discussion at the French residence today, leading national stakeholders are gathering—at the initiative of Business France, Nordic Infucare, and Sanofi—to translate strategic dialogues in life science into concrete directions for Europe's innovative capacity. This joint initiative deepens the French-Swedish collaboration within the framework of the renewed strategic innovation partnership, with the aim of securing Sweden's and France's roles as a European hub for medical innovation.

The European life science sector faces significant challenges as a result of geopolitical shifts and trade policy decisions, such as the US 'Most-Favored-Nation' (MFN) policy. Today's meeting brings together key stakeholders to focus on how good access to innovative medicines and medical technology can be secured—and how we can bridge the gap between innovation and actual implementation in healthcare.

Determination for the healthcare of the future

In connection with today's meeting, the importance of translating shared visions into practical benefits to secure health, patient value, and future investments is emphasized:

”Through this initiative, we strive for a deepened dialogue and broad collaboration with the goal of contributing to concrete directions that benefit individuals, healthcare, and society at large, where the partnership between France and Sweden constitutes a vital foundation. To maintain a strong position, it is urgent that we keep a high pace in our work to secure health and investments in medical innovation, as well as enable smooth implementation for the individuals concerned in Sweden,” Nordic Infucare, Sanofi, and Business France summarize in a joint statement.

Strategic autonomy as a priority

The Ambassador of France to Sweden, His Excellency Thierry Carlier, who is hosting today's talks, emphasizes the importance of collaboration:

”This collaboration between France and Sweden is essential for building a more resilient European life science base. By joining forces in broad partnerships, strategic autonomy can be protected and citizens' stable access to both tomorrow's medical breakthroughs and innovative medical technology solutions can be ensured.”

Strategic directions for the life science of the future

With the French-Swedish partnership as a foundation, today's efforts focus on the following areas:

  • Geopolitics and European competitiveness: How Sweden and France can jointly strengthen Europe's life science base in a changing global landscape.
  • Securing investments and incentive structures: Framework conditions, reimbursement models, and how we retain research, development (R&D), and manufacturing.
  • Accessibility and resilient healthcare systems: To complete introduction from innovation to implementation through person-centered, digital health and close care.

Innovation as a foundation for national security

Today's initiative underscores that an environment that promotes medical progress is of central importance to society's innovative capacity. Through the strategic partnership between France and Sweden, this foundation can create the conditions for broad collaboration aimed at exploring how we can best build shared infrastructure and establish models that support long-term and robust preparedness in a changing world.

Links / Attachments:

For more information, please contact:

Madeleine Wallding, Nordic Business Unit Director, Nordic Infucare, +46 (0)72-508 79 50 madeleine.wallding@infucare.com

Daniel Sandgren, Country Manager, Sanofi Sweden, +46 (0)72-545 36 35  Daniel.sandgren@sanofi.com

Melanie Gaudin, Director for the Nordic Countries at Business France, +46 (0)70-016 93 34 melanie.gaudin@businessfrance.fr

About Business France – French Embassy in Sweden

Business France is the public consulting business serving the international development of the French economy. It is responsible for fostering export-led growth by French businesses, as well as promoting and facilitating foreign investment in France. It promotes France’s firms, business image and nationwide attractiveness as an investment location, and also runs the V.I.E program. Business France has more than 1,400 personnel, both in France and in 53 countries throughout the world. Part of the French Embassy in Sweden, Business France in Sweden brings together a team of 15 experts and acts as a key facilitator of Franco-Swedish economic relations, supporting trade, investment, and innovation partnerships. https://world.businessfrance.fr/nordic/;

About Nordic Infucare

Nordic Infucare is specialised in the distribution of innovative medicines, medical technology, and treatment support to enable person-centered care. With its headquarters in Bromma and approximately 140 employees, the company is a leading player in the Nordic region. As part of the French Air Liquide Group, Nordic Infucare combines Nordic expertise with global innovative capacity. Through its healthcare division, Air Liquide Healthcare, the group works daily to develop healthcare solutions of the future and improve the quality of life for millions of patients in over 70 countries https://www.infucare.com/

About Sanofi

We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across more than 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. www.sanofi.com/sv/sverige.